Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Pharmacogenomic network analysis of the gene-drug interaction landscape underlying drug disposition. Local targets link to admitted publications; unresolved targets remain external evidence.
Postmarket safety events among novel therapeutics approved by the US food and drug administration between 2001 and 2010
10.1001/jama.2017.5150 · 2017 · External reference
Incidence of adverse drug reactions in hospitalized patients
10.1001/jama.279.15.1200 · 1998 · External reference
10.1038/nrd1874
10.1038/nrd1874 · External reference
Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study
10.1038/clpt.2008.157 · 2009 · External reference
Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy
10.1373/clinchem.2004.041327 · 2005 · External reference
10.1146/annurev-pharmtox-010611-134520
10.1146/annurev-pharmtox-010611-134520 · External reference
10.1146/annurev-biodatasci-080917-013444
10.1146/annurev-biodatasci-080917-013444 · External reference
10.1371/journal.pcbi.1002998
10.1371/journal.pcbi.1002998 · External reference
10.1038/s41467-018-05116-5
10.1038/s41467-018-05116-5 · External reference
Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing
10.1038/srep32745 · 2016 · External reference
10.1038/s41467-019-10744-6
10.1038/s41467-019-10744-6 · External reference
10.1038/s41467-019-09186-x
10.1038/s41467-019-09186-x · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Integrating rare genetic variants into pharmacogenetic drug response predictions
10.1186/s40246-018-0157-3 · 2018 · External reference
10.1038/nature19057
10.1038/nature19057 · External reference
10.1038/s41397-018-0044-2
10.1038/s41397-018-0044-2 · External reference
10.1007/s11192-009-0146-3
10.1007/s11192-009-0146-3 · External reference
Examining similarity structure: multidimensional scaling and related approaches in neuroimaging
10.1155/2013/796183 · 2013 · External reference
10.25080/tcwv9851
10.25080/tcwv9851 · External reference
10.1124/mol.106.025288
10.1124/mol.106.025288 · External reference
10.1016/j.ejps.2019.01.024
10.1016/j.ejps.2019.01.024 · External reference
10.1002/cpt.258
10.1002/cpt.258 · External reference
10.1038/nature08494
10.1038/nature08494 · External reference
10.1093/hmg/ddt588
10.1093/hmg/ddt588 · External reference
10.1097/fpc.0000000000000172
10.1097/fpc.0000000000000172 · External reference
Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network
10.1002/cpt.350 · 2016 · External reference
Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics
10.1038/gim.2017.156 · 2018 · External reference
10.1038/tpj.2016.77
10.1038/tpj.2016.77 · External reference
Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews
10.1136/jmedgenet-2018-105429 · 2018 · External reference
Genetic variability and population diversity of the human SLCO (OATP) transporter family
10.1016/j.phrs.2018.10.017 · 2019 · External reference
10.1007/s00439-019-02081-x
10.1007/s00439-019-02081-x · External reference
Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response
10.1038/gim.2016.33 · 2017 · External reference
10.1016/j.tips.2016.05.006
10.1016/j.tips.2016.05.006 · External reference
10.1016/j.tips.2015.10.006
10.1016/j.tips.2015.10.006 · External reference
How to consider rare genetic variants in personalized drug therapy
10.1002/cpt.976 · 2018 · External reference
10.1073/pnas.0603236103
10.1073/pnas.0603236103 · External reference
10.1126/science.aar7389
10.1126/science.aar7389 · External reference
10.1124/pr.110.002584
10.1124/pr.110.002584 · External reference
Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10
10.1124/dmd.109.028225 · 2009 · External reference
10.1016/j.mam.2012.05.007
10.1016/j.mam.2012.05.007 · External reference
Centrality in modular networks
10.1140/epjds/s13688-019-0195-7 · 2019 · External reference
10.1038/s41598-017-07209-5
10.1038/s41598-017-07209-5 · External reference
Ollivier-ricci curvature-based method to community detection in complex networks
2019 · External reference
10.1073/pnas.0601602103
10.1073/pnas.0601602103 · External reference
Near linear time algorithm to detect community structures in large-scale networks
10.1103/physreve.76.036106 · 2007 · External reference
